Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
November 20, 2016 - February 14, 2017
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
1992
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.6 (Skin Sensitisation)
Version / remarks:
2008
Deviations:
no
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.2600 (Skin Sensitisation)
Version / remarks:
2003
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
FREY-TOX GmbH, Osteroda 38, 04916 Herzberg/Elster
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
The guinea pig test method described in OECD TG 406 provide suitable information for hazard identification.

Test material

Reference
Name:
Unnamed
Type:
Constituent
Test material form:
liquid
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: CA AQ02372
- expiry date: 17 June 2018

STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature




In vivo test system

Test animals

Species:
guinea pig
Strain:
Dunkin-Hartley
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Envigo RMS GmbH
- Microbiological status of animals, when known: SPF
- Weight at study initiation: 328-360 g
- Housing: macrolone cages, two or three animals per cage
- Diet: ad libitum, pelleted diet "Altromin 3123"
- Water: ad libitum, domestic quality drinking water being enriched with vitamin C and acidified with hydrochloric acid to pH 2.5
- Acclimation period: 5 days
- Indication of any skin lesions: no

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20±3
- Humidity (%): 30-70
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal
Vehicle:
water
Concentration / amount:
2.5% (w/w) test item/dose volume 0.1 mL

Day(s)/duration:
Day 0
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
test group with 100% test item
Day(s)/duration:
Day 7/48 h
Challenge
No.:
#1
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
100% test item
Day(s)/duration:
Day 21/24 hours
No. of animals per dose:
control group: 5
test group: 10
Details on study design:
RANGE FINDING TESTS:
A pre-test was conducted to determine the concentrations for the main test. Three animals were used per concentration.
Intradermal: 2.5 and 5% tested
Dermal: 25, 50, 75 and 100% tested

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2
1. Intradermal:
- Test groups: 3 pairwise arranged injections:
Injection (1): 1:1-mixture (v/v) of FCA and NaCl 0.9%
Injection (2): 2.5% (w/w) test item in the vehicle aqua dest.
Injection (3): 2.5% (w/w) test item in a 1:1-mixture (v/v) of FCA and NaCl 0.9%
- Control group: 3 pairwise arranged injections:
Injection (1): 1:1-mixture (v/v) of FCA and NaCl 0.9%
Injection (2): vehicle aqua dest.
Injection (3): 50% (w/v) preparation of the vehicle aqua dest. in a 1:1-mixture (v/v) of FCA and NaCl 0.9%
- Site: scapular region
- Frequency of applications: once
- Concentrations: 2.5% test item

2. Dermal:
- Site: scapular region
- Test groups:
Complete loading (0.5 mL) of patch with test item
- Control group:
Complete loading (0.5 mL) of patch with vehicle
- Exposure time: 48 hours
- Concentrations: 100% test item

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: Day 21
- Exposure period: 24 hours
- Test groups: patch with 100% test item
- Control group: patch with vehicle
- Site: caudal right flank
- Evaluation (hr after challenge): after 24 and 48 hours

C. ASSESSMENT OF SKIN REACTIONS
- According to grading scale by Magnusson/Kligmann
No visible change : grade 0
Discrete or patchy erythema: grade 1
Moderate and confluent erythema: grade 2
Intense erythema and swelling: grade 3
Positive control substance(s):
no
Remarks:
but data from the last positive control study with the reference material alpha-Hexylcinnamaldehyde, technical grade, 85% conducted from January to February 2017 were provided.

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
100%
No. with + reactions:
8
Total no. in group:
10
Clinical observations:
skin reactions of grade 2 (moderate and confluent erythema) in 3 animals and skin reactions grade 1 (discrete or patchy erythema) in 5 animals
Remarks on result:
positive indication of skin sensitisation
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
0%
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
no visible changes
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
100%
No. with + reactions:
6
Total no. in group:
10
Clinical observations:
Skin reactions of grade 2 in 3 animals and skin reactions of grade 1 in 3 animals
Remarks on result:
positive indication of skin sensitisation
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
0%
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
no visible changes
Remarks on result:
no indication of skin sensitisation

Applicant's summary and conclusion

Interpretation of results:
Category 1A (indication of significant skin sensitising potential) based on GHS criteria